ArticleResearch and practice in thrombosis and haemostasis2024

The anticoagulant effects of milvexian, a novel small molecule factor XIa inhibitor, are neutralized by activated prothrombin complex concentrates and recombinant factor VIIa in human plasma and whole blood

Matthew Bunce et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.